Skip to content

Feasibility Study of Sentinel Navigation Surgery After Non-curative Endoscopic Resection

Feasibility Study of Sentinel Navigation Surgery in Early Gastric Cancer Patients After Non-curative Endoscopic Resection

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03123042
Acronym
SENORITA2
Enrollment
243
Registered
2017-04-21
Start date
2017-03-20
Completion date
2024-12-31
Last updated
2025-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early Gastric Cancer, Sentinel Lymph Node

Keywords

Sentinel lymph node, Early gastric cancer, Non-curative endoscopic resection

Brief summary

Purpose: To prove the feasibility of sentinel node navigation surgery (SNNS) in early gastric cancer patients with the risk of lymph node metastasis after endoscopic resection and preparation of multicenter phase 3 trial of stomach preserving surgery in these patients. Contents: The number of enrollment is 247 patients. The patients underwent endoscopic resection for early gastric cancer, and the tumor was defined to be out of indication for endoscopic resection pathologically. So, additional gastrectomy is recommended for them. The investigators will enroll patients who agree this study. After general anesthesia, Tc99m-Phytate with indocyanine green will be injected with endoscopy. Then sentinel basin will be detected using gamma probe and laparoscopic basin dissection will be done. Sentinel lymph node will be identify in back table dissection, and patients will undergo conventional gastrectomy. Detection rate and false negative rate will be evaluated by pathological review.

Detailed description

Sentinel basin dissection method 1. endoscopic tracer injection after general anesthesia 2. Tracer : Tc99m-phytate 3cc and indocyanine green 3cc mix --\> Injection of the probe (1cc/site, 4 sites) around endoscopic submucosal dissection ulcer scar 3. Sentinel basin identification with laparoscopic probe 4. Dissection of the sentinel basin 5. Sentinel node dissection at back table 6. Conventional laparoscopic gastrectomy

Interventions

PROCEDURESentinel basin dissection

Sentinel basin detection using endoscopic detector (Tc99m plus indocyanine green) injection and laparoscopic sentinel basin dissection. Then conventional gastrectomy

Sponsors

National Cancer Center, Korea
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* No limitation for age if the patient is available for gastrectomy * Patient who underwent endoscopic submucosal dissection and the tumor was defined as out of indication. The expanded criteria for endoscopic resection are as follows * criterion I: intramucosal tumor without ulcerative findings and of differentiated type with size \> 2 cm * criterion II: intramucosal tumor with ulcerative findings and of differentiated type with size ≤ 3 cm * criterion III: intramucosal tumor without ulcerative findings and of undifferentiated type with size \< 2 cm * criterion IV, submucosal invasion \< 500 mm and of differentiated type with size ≤ 3 cm) * Eastern Cooperative Oncology Group (ECOG) performance scale 0 or 1

Exclusion criteria

* Inoperative due to severe cardiovascular or pulmonary disease * Pregnant * Patients who had previous gastric surgery * Patients who had previous upper abdomen surgery except cholecystectomy, or radiation therapy on upper abdomen, or hypersensitivity to any medicine

Design outcomes

Primary

MeasureTime frameDescription
detection rate (%)15 days after operationnumber of patients whose sentinel nodes are detected / enrolled number of patients \*100

Secondary

MeasureTime frameDescription
False negative rate15 days after operationnumber of patients without metastatic lymph node in sentinel basin / number of patients with metastatic lymph node \*100

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026